ropivacaine + tramadol

Ropivacaine + tramadol is a combination of two drugs used primarily for regional anesthesia and postoperative pain management. Ropivacaine is a long-acting amide local anesthetic that works by blocking sodium channels in neuronal membranes, thereby inhibiting the propagation of nerve impulses and providing sensory blockade. Tramadol is a centrally acting analgesic with dual mechanisms: it acts as a weak agonist at the μ-opioid receptor and inhibits the reuptake of serotonin and norepinephrine, enhancing its analgesic efficacy. The combination leverages both peripheral (ropivacaine) and central (tramadol) mechanisms to provide more potent and prolonged analgesia than either agent alone, particularly in the immediate postoperative period[5][6][1]. This combination has been studied for use in epidural, perineural, intrathecal, and intra-articular administration during various surgical procedures such as lower abdominal surgery, shoulder surgery, or knee arthroplasty[1][4][9]. The addition of tramadol may reduce opioid requirements postoperatively while maintaining effective pain control.

Other names

Ropivacaine and tramadol combinationRopivacaine + Tramadol